Suzuken Co., Ltd.

9987.T
Medical Distribution
2026/10/23 10:54 Updated
Market Cap: $2.4B (¥381.8B)
Stock Price: $18.27 (¥2,863)
Exchange Rate: 1 USD = ¥156.74

Notice Regarding the Impact of the 2026 Kumamoto Earthquake: Resumption of Production at Kumamoto Plant

As an update on disclosures related to the Kumamoto earthquake, Suzuken Co., Ltd. announced that production at the Sanwa Chemical Research Institute Kumamoto Plant is scheduled to resume from October 19. The company states it will prioritize safety inspections and GMP compliance while working to ensure stable supply.

Importance:
Page Updated: October 16, 2026
IR Disclosure Date: October 16, 2026

Key Figures

  • Recovery / resumption date: 2026-10-19
  • Earthquake occurrence date: 2026-07-28 (mentioned in text)
  • Policy on revising production plans before and after resumption: Unknown

AI要約

Key Points on Production Resumption

The Kumamoto Plant has completed equipment inspections and safety confirmations following the earthquake, and after recovery actions consistent with GMP, production will resume from Monday, October 19. The company emphasizes that securing employee safety is the top priority and that repairs and resumption conditions were judged to be in order.

Efforts Toward Stable Supply Going Forward

Going forward, production plans will be reviewed as appropriate, and for contract-manufactured products the company will strengthen coordination with client companies to secure stable supply. The Kumamoto Plant's safety and quality will be prioritized, and efforts will be made to further reinforce the production system.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Suzuken Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →